MEK1/2在脂多糖诱导人脐静脉内皮细胞ICAM-1表达中的作用

目的：探讨MEK1/2在脂多糖诱导人脐静脉内皮细胞（HUVECs）ICAM-1表达中的作用。 方法： 用不同浓度LPS或LPS加MEK1/2特异性抑制剂PD98059和HUVECs孵育不同时间后，分别采用RT-PCR和Western blotting检测ICAM-1 mRNA和蛋白的表达。 结果： LPS呈时间-浓度依赖性地上调HUVECs ICAM-1 mRNA和蛋白的表达。LPS预处理后2 h，HUVECs ICAM-1 mRNA和蛋白的表达即开始升高，LPS(100 μg·L-1)作用后6 h,ICAM-1 mRNA和蛋白的表达基本达到高峰；PD98059(10 μg·L-1)可显著抑制LPS(100 μg·L-1)诱导6 h的ICAM-1 mRNA和蛋白的表达，抑制率分别为54.4%和44.9%（P<0.01 vs LPS）。 结论： 调控MEK1/2通路可能为内毒素休克诱导血管内皮损伤的防治提供新的策略。

Role of MEK1/2 in ICAM-1 over expression induced by lipopolysaccharide in human umbilical vein endothelial cells

AIM: To investigate the role of MEK1/2, a subfamily of mitogen activated protein kinase-kinase (MAPKK), in expression of intercellular adhesion molecule-1 (ICAM-1) induced by lipopolysaccharide (LPS) in human umbilical vein endothelial cells (HUVECs). METHODS: Expression levels of ICAM-1 mRNA and its protein were assayed using RT-PCR and Western blotting, respectively, in HUVECs pretreated with different concentrations of LPS for different times with or without PD98059, a specific inhibitor of MEK1/2. RESULTS: LPS up-regulated the expression of ICAM-1 mRNA and its protein in HUVECs in a concentration- and time-dependent manners. The expression levels of ICAM-1 mRNA and its protein began to elevate at 2 h after LPS treatment, and reached nearly a peak value at 6 h after LPS (100 μg·L-1) treatment. PD98059 (10 μg·L-1) significantly inhibited LPS-induced expression of ICAM-1 mRNA and protein, the expression inhibitory rates of which were 54.4% and 44.9%, respectively (P<0.01). CONCLUSION: Modulation of MEK1/2 signaling pathway might be a new and useful strategy for the prevention and treatment of vascular endothelial injury induced by LPS.